Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells

Inflammatory Bowel Diseases

Volumn 16, Issue 3, 2010, Pages 410-427

  Ghadimi, Darab ^a   De Vrese, Michael ^a   Heller, Knut J ^a   Schrezenmeir, Juergen ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

Author keywords

Gene expression; Intestinal epithelial cells; Probiotic DNA; TLRs

Indexed keywords

BACTERIAL DNA; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROBIOTIC AGENT; RNA 16S; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIUM CULTURE; BASOLATERAL MEMBRANE; BIFIDOBACTERIUM LONGUM; CELL POLARITY; CELL VIABILITY; COMMENSAL; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTRIC RESISTANCE; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BIOLOGICAL PRODUCTS; CELL POLARITY; CELL SURVIVAL; DNA, BACTERIAL; ELECTRIC IMPEDANCE; GENE EXPRESSION; HT29 CELLS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-8; INTESTINAL MUCOSA; LACTOBACILLUS RHAMNOSUS; LIPOPOLYSACCHARIDES; LUCIFERASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROBIOTICS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77149150067     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21057     Document Type: Article

References (66)

1. Abreu MT, Vora P, Faure E, et al. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol. 2001;167:1609-1616.
2. Abreu MT, Arnold ET, Thomas LS, et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem. 2002;277:20431-20437.
3. Alander M, Satokari R, Korpela R, et al. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol. 1999;65: 351-354.
4. Altenhoefer A, Oswald S, Sonnenborn U, et al. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol. 2004;40:223-229.
5. Bai AP, Ouyang Q, Zhang W, et al. Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT-29 cells. World J Gastroenterol. 2004;10:455-457.
6. Berkes J, Viswanathan VK, Savkovic SD, et al. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 2003;52:439-451.
7. Bleich A, Janus LM, Smoczek A, et al. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroentrology. 2009;136:278-287.
8. Daig R, Andus T, Aschenbrenner E, et al. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut. 1995;38:216-222.
9. Dalpke A, Frank J, Peter M, et al. Activation of Toll-like receptor 9 by DNA from different bacterial species. Infect. Immun. 2006;74: 940-946.
10. de Vrese M, Winkler P, Rautenberg P, et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/ 5 on common cold episodes: a double blind, randomised, controlled trial. Clin Nutr. 2005;24:481-491.
11. Ewaschuk JB, Backer JL, Churchill TA, et al. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun. 2007;75: 2572-2579.
12. Fiocchi C. Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol Gastrointest Liver Physiol. 1997;273:G769-G775.
13. Gewirtz AT, Simon PO Jr, Schmitt CK, et al. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest. 2001b;107:99-109.
14. Gribar SC, Anand RJ, Leaphart CL, et al. Toll like receptor 9 signaling attenuates the responsiveness of Toll like receptor 4 to endotoxin in enterocytes. J Surg Res. 2007;137:153.
15. Gribar SC, Richardson WM, Kohler JW, et al. Toll-like receptor 9 (TLR9) activation attenuates TLR4-mediated signaling in enterocytes and reduces the severity of experimental necrotizing enterocolitis. J Am Coll Surg. 2008a;207:S55.
16. Gribar SC, Evans AC, Richardson WM, et al. The TLR9 agonist CpG-DNA protects against LPS-induced enterocyte apoptosis through the up-regulation of heat shock protein 70 and reduces the severity of necrotizing enterocolitis in mice. J Surg Res. 2008b;144:268.
17. Haller D, Russo MP, Sartor RB, et al. IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem. 2002; 277:38168-38178.
18. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18: 2195-2224.
19. Haarman M, Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2006;72:2359-2365.
20. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408:740-745.
21. Jijon HB, Panenka WJ, Madsen KL, et al. MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism. Am J Physiol Cell Physiol. 2002;283:C31-C41.
22. Jijon H, Backer J, Diaz H,et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology. 2004;126:1358-1373.
23. Jobin C, Sartor RB. The I kappa B/NF-kB system: a key determinant of mucosal inflammation and protection. Am J Physiol. 2000;278: C451-C462.
24. Kamada N, Inoue N, Hisamatsu T, et al. Nonpathogenic Escherichia coli Strain Nissle 1917 prevents murine acute and chronic colitis. Inflamm Bowel Dis. 2005;11:455-463.
25. Kandimalla ER, Bhagat L, Yu D, et al. Conjugation of ligands at the 5′-end of CpG DNA affects immunostimulatory activity. Bioconj Chem. 2002;13:966-974.
26. Kandimalla ER, Bhagat L, Wang D, et al. Divergent synthetic nucleotide motif recognition pattern: design and development of potent immunomodulatory oligodeoxyribonucleotide agents with distinct cytokine induction profiles. Nucleic Acids Res. 2003;31:2393-2400.
27. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18: 621-663.
28. Katakura K, Lee J, Rachmilewitz D, et al. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest. 2005;115:695-702.
29. Katz KD, Hollander D, Vadheim CM, et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology. 1989;97:927-931.
30. Klingberg TD, Pedersen MH, Cencic A, et al. Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Appl Environ Microbiol. 2005;71:7528-7530.
31. Ko JS, Yang HR, Chang JY, et al. Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alpha. World J Gastroentrol. 2007;13:1962-1965.
32. Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nature Rev. 2006;5:471-484.
33. Kunzelmann K, McMorran B. First encounter: how pathogens compromise epithelial transport. Physiology (Bethesda). 2004;19:240-244.
34. Kuo CC, Liang SM, Liang CM. CpG-B oligodeoxynucleotide promotes cell survival via up-regulation of Hsp70 to increase Bcl-xL and to decrease apoptosis-inducing factor translocation. J Biol Chem. 2006;281:38200-38207.
35. Lee J, Mo JH, Katakura K, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 sigballing in intestinal epithelial cells. Nat Cell Biol. 2006;8:1327-1336.
36. Lee J, Mo JH, Shen C, et al. Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr Opin Gastroenterol. 2007;23:27-31.
37. Lee J, Gonzales-Navajas JM, Raz E. The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol. 2008;30:3-9.
38. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2:725-734.
39. Luyer MD, Buurman WA, Hadfoune M, et al. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun. 2005;73:3686-3692.
40. Ma TY, Iwamoto GK, Hoa NT, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastro Liver Physiol. 2004;286:G367-G376.
41. Nasuhara Y, Adcock IM, Catley M, et al. Differential IkappaB kinase activation and IkappaBalpha degradation by interleukin-1beta and tumor necrosis factor-alpha in human U937 monocytic cells. Evidence for additional regulatory steps in kappaB-dependent transcription. J Biol Chem. 1999;274:19965-19972.
42. Neurath MF, Becker C, Barbulescu K. Role of NF-kappaB in immune and inflammatory responses in the gut. Gut. 1998;43:856-860.
43. + T cells which prevent intestinal inflammation in the SCID transfer model of colitis. Gut. 2005;54:1428-1436.
44. Oshima T, Miwa H, Joh T. Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. Am J Physiol Cell Physiol. 2008;295:C800-C806.
45. Palazzo M, Gariboldi S, Zanobbio L, et al. Cross-talk among Toll-like receptors and their ligands. Int Immunol. 2008;20:709-718.
46. Pedersen G, Andresen L, Matthiessen MW, et al. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Clin Exp Immunol. 2005;141:298-306.
47. Petrof EO, Kojima K, Ropeleski MJ, et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology. 2004;127: 1474-1487.
48. Pitman RS, Blumberg RS. First line of defense: the role of the intestinal epithelium as an active component of the mucosal immune system. J Gastroenterol. 2000;35:805-814.
49. Plevy SE, Landers CJ, Prehn J, et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol. 1997;159:6276 82.
50. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-429.
51. Rachmilewitz D, Karmeli F, Takabayashi K, et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology. 2002;122:1428-1441.
52. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the ant-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 2004;126:520-528.
53. Rachmilewitz D, Karmeli F, Shteingart S, et al. Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis. Inflamm Bowel Dis. 2006;12:339-345.
54. Raz E. How TLRs can be mucosal protective. Session: Molcular basis of innate defense in the intestine. Gastroenterology. 2006;130(Suppl 2):P-100.Sp494.
55. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology. 2006;130:731-746.
56. Riedel CU, Foata F, Philippe D, et al. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-κB activation. World J Gastroenterol. 2006;12:3729-3735.
57. Roselli M, Finamore A, Britti MS, et al. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br J Nutr. 2006;95:1177-1184.
58. Sambrook J, Russel DW. Molecular Cloning. 3rd ed. New York: Cold Spring Harbor Laboratory Press;2001.
59. Sandle GI, Higgs N, Crowe P, et al. Cellular basis for defective electrolyte transport in inflamed human colon. Gastroenterology. 1990;99: 97-105.
60. Schmitz H, Fromm M, Bentzel CJ, et al. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci. 1999;112:137-146.
61. Simmonds A, LaGamma EF. Addressing the "New" NEC: Part I: rediscovering the basics. Indian J Pediatr. 2006;73:1011-1018.
62. van Deventer SJ. Chemokine production by intestinal epithelial cells: a therapeutic target in inflammatory bowel disease? Aliment Pharmacol Ther. 1997;11(Suppl 3):116-121.
63. Vollmer J, Weeratna RD, Jurk M, et al. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent Thelper type 2 biased immune stimulation. Immunology. 2004;113:212-223.
64. Winkler P, Ghadimi D, Schrezenmeir J, et al. Molecular and cellular basis of microflora-host interactions. J Nutr. 2007;137:756S-72S.
65. Xavier RJ, Podolsky DK. How to get al.ng - friendly microbes in a hostile world. Science. 2000;289:1483-1484.
66. Zhang L, Li N, Caicedo R, et al. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-a-induced interleukin-8 production in Caco-2 cells. J Nutr. 2005;135:1752-1756.